E.E. Geduld’s MediciNova MNOV Stock Holding History

E.E. Geduld’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-10,000	Closed	-$73K	–	176
2016 Q1	$73K	Buy	+10,000	New	+$49.5K	0.1%	112

Other funds holding MNOV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

E.E. Geduld's MNOV Position: Q2 2016 in Review

E.E. Geduld sold out of MediciNova (MNOV) in Q2 2016, closing a stake of 10,000 shares — an estimated $73K sold.

E.E. Geduld first reported a position in MNOV in Q1 2016 and held it in 1 quarter. The position peaked at $73K in Q1 2016. 48 funds tracked by Wall St. Rank hold MNOV as of Q2 2016.

E.E. Geduld reported no remaining MediciNova position as of Q2 2016 after selling out during the quarter.
E.E. Geduld sold 10,000 MediciNova shares in Q2 2016, an estimated $73K.
E.E. Geduld first reported a position in MediciNova in Q1 2016 and held it in 1 quarter.
E.E. Geduld's MediciNova position peaked at $73K in Q1 2016.
48 funds tracked by Wall St. Rank held MediciNova as of Q2 2016.

Based on E.E. Geduld's 13F filing for Q2 2016, filed 8 Aug 2016.